Related Experiment Video
Updated: Jun 28, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Complicated pneumonia caused by group A Streptococcus in children - 2022/2023 infectious season outbreak and update
Magdalena Grochowska1, Agnieszka Strzelak2, Katarzyna Krenke2
1Department of Pediatric Pulmonology and Allergy, Medical University of Warsaw, Warsaw, Poland; Doctoral School, Medical University of Warsaw, Warsaw, Poland.
Insights
Group A Streptococcus (GAS) is the leading cause of complicated pediatric pneumonia post-pandemic. Early recognition of scarlet fever symptoms and viral infections is crucial for managing this severe condition.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Medicine
- Microbiology
Background:
- Increased incidence of Group A Streptococcus (GAS) infections in children post-COVID-19 pandemic.
- Limited data on GAS contribution to complicated community-acquired pneumonia (CAP).
- Need to understand pulmonary manifestations of GAS in pediatric populations.
Purpose of the Study:
- To determine the role of GAS in complicated CAP in children.
- To analyze the clinical presentation and outcomes of GAS-related complicated CAP.
- To assess GAS as a cause of pediatric pneumonia during the 2022/2023 season.
Main Methods:
- Retrospective analysis of complicated CAP cases in hospitalized children.
- Study conducted at a tertiary care center in Warsaw, Poland.
- Inclusion period: August 2022 to May 2023.
Main Results:
- GAS was the dominant pathogen in complicated CAP (24.2%).
- GAS pneumonia cases often presented with scarlet fever (68.2%) and viral infections (27.3%).
- GAS complicated CAP involved longer hospitalization and more chest tube insertions, but shorter drainage duration; associated with higher procalcitonin and lower platelets.
Conclusions:
- Group A Streptococcus is the predominant pathogen causing complicated CAP in children.
- Clinicians must recognize the current epidemiology and potential severity of GAS pneumonia.
- Close monitoring is advised for children with scarlet fever and preceding viral infections.
Background:
An increased incidence of group A Streptococcus (GAS) infections has been observed in pediatric population post-COVID-19 pandemic. While the majority of reports refer to scarlet fever or invasive GAS disease, detailed data on pulmonary manifestations such as complicated community-acquired pneumonia (CAP) are scarce. The aim of this study was to assess the contribution of GAS to complicated CAP in children during the 2022/2023 infectious season.
Methods:
We retrospectively analyzed the etiology and clinical presentation of complicated CAP patients hospitalized in our tertiary care center in Warsaw, Poland, between August 2022 and May 2023.
Results:
Among 91 patients with complicated CAP, GAS was the dominant cause constituting 24.2% (22/91; 95% CI 15.8-34.3%) of the study group. 68.2% of GAS pneumonia patients presented symptoms of scarlet fever, and 27.3% had preceding or concurrent viral infection. GAS complicated CAP was associated with longer hospitalization, higher incidence of chest tube insertion, but shorter duration of chest tube drainage than complicated CAP of other etiology. Children with GAS complicated CAP had higher procalcitonin concentration (28.1 vs. 1.5 ng/dL; p<0.0001) and a lower platelets level (254.5 vs. 422 × 103/μL; p = 0.0031) than those with non-GAS infection.
Conclusions:
GAS is currently the predominant pathogen of complicated CAP in children. Clinicians should be aware of the current epidemiological situation and a more severe course of GAS pneumonia in this age group, and should monitor patients presenting with symptoms of scarlet fever and preceding viral infection closely.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:

